Serum β-hCG, AMH, TSH, and PRL Levels in Predicting the Outcome of Early Pregnancy 14 Days after Embryo Transfer: A Prospective Cohort Study
- PMID: 40519571
- PMCID: PMC12165297
- DOI: 10.4103/abr.abr_285_23
Serum β-hCG, AMH, TSH, and PRL Levels in Predicting the Outcome of Early Pregnancy 14 Days after Embryo Transfer: A Prospective Cohort Study
Abstract
Background: Pregnancy outcomes in assisted reproductive technology (ART) are influenced by the ability of the embryos to create a pregnancy and maternal factors such as hormone levels to maintain and develop the pregnancy. This study investigated the role of β-human chorionic gonadotropin (β-hCG), anti-mullerian hormone (AMH), thyroid-stimulating hormone (TSH), and prolactin (PRL) in predicting pregnancy outcomes and determined cutoff values in women undergoing ARTs.
Materials and methods: This prospective study included 153 women who underwent infertility treatment in the Department of Reproductive Medicine of the Yas Hospital, Tehran University of Medical Sciences (Tehran, Iran). Serum β-hCG level on day 14 after embryo transfer and serum AMH, TSH, and PRL were measured. Patients with β-hCG levels >25 mIU/ml were included in the study. Finally, any statistically significant relationships between these serum values and clinical pregnancy and live birth rate were investigated. To predict pregnancy outcomes with β-hCG levels, a receiver operating characteristic curve was used to estimate the β-hCG cutoff values.
Results: Serum β-hCG levels were significantly higher in live-birth patients than in other patients. The β-hCG cutoff value for live births was 830 mIU/ml, with an AUC of 0.5920, sensitivity of 61.04%, and specificity of 56.58%. Serum AMH, TSH, and PRL levels did not show any significant results.
Conclusions: Serum β-hCG levels on day 14 after embryo transfer can be used to predict the probability of live birth in patients undergoing infertility treatment.
Keywords: Embryo transfer; human chorionic-gonadotropin; pregnancy outcomes.
Copyright: © 2025 Advanced Biomedical Research.
Conflict of interest statement
There are no conflicts of interest.
Figures



Similar articles
-
Possibility of live birth in patients with low serum β-hCG 14 days after blastocyst transfer.J Ovarian Res. 2020 Nov 12;13(1):132. doi: 10.1186/s13048-020-00732-6. J Ovarian Res. 2020. PMID: 33183346 Free PMC article.
-
Diagnostic value of a single β-hCG test in predicting reproductive outcomes in women undergoing cleavage embryo transfer: a retrospective analysis from a single center.Reprod Health. 2022 Jun 22;19(1):145. doi: 10.1186/s12978-022-01455-1. Reprod Health. 2022. PMID: 35733148 Free PMC article.
-
Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.Hum Reprod. 2019 Nov 1;34(11):2244-2253. doi: 10.1093/humrep/dez186. Hum Reprod. 2019. PMID: 31725884
-
Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.Cochrane Database Syst Rev. 2018 Oct 20;10(10):CD011537. doi: 10.1002/14651858.CD011537.pub3. Cochrane Database Syst Rev. 2018. PMID: 30341915 Free PMC article. Review.
-
Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis.Hum Reprod. 2023 Sep 5;38(9):1789-1806. doi: 10.1093/humrep/dead147. Hum Reprod. 2023. PMID: 37475164
References
-
- Granger E, Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62:238–56. - PubMed
LinkOut - more resources
Full Text Sources